Skyscape Web Viewer : Antibiotics Simplified : Main Index

View All
Amphotericin B lipid formulations of described
Ampicillin General Approach to Infectious Diseases described susceptibility breakpoints
Ampicillin/sulbactam, described
Anaerobes cephalosporins and penicillins and cephalosporins and cephamycins and
Anaphylaxis Adverse Consequences of Antibiotic Use Carbapenems Beta-Lactams Cephalosporins
Anidulafungin, described
Antibiotic(s) avoiding using to treat colonization or contamination bioavailability of defined macrolide using the proper dose bioavailability of clinically useful spectra of activity for empiric selection of guidance for utilizing susceptibility testing of using the shortest effective duration of therapy
Antibiotic allergy
Antibiotic pharmacodynamics pharmacokinetic/pharmacodynamic relationships susceptibility testing defined static versus cidal
Antibiotic pharmacokinetics defined metabolism/excretion absorption distribution phases and parameters
Antibiotic pressure, and collateral damage
Antibiotic toxicities
Anti-coronavirus antivirals agents mechanism of action nirmatrelvir/ritonavir spectrum adverse effects Anti-Coronavirus Antivirals molnupiravir remdesivir
Anti-cytomegalovirus agents Anti-Cytomegalovirus Agents foscarnet letermovir valganciclovir adverse effects cidofovir ganciclovir mechanisms of action
Antifungal antimetabolites agents mechanism of action adverse effects flucytosine (5-FC)
Antifungals introduction to clinically useful spectra of activity for empiric selection of
Anti-herpes simplex virus agents acyclovir Anti-Herpes Simplex Virus and Varicella-Zoster Virus Agents famciclovir valacyclovir acyclovir adverse effects famciclovir mechanism of action valacyclovir
Antiinfective, defined
Anti-influenza antivirals adverse effects Anti-Influenza Antivirals baloxavir oseltamivir spectrum agents Antimicrobial, defined mechanism of action peramivir zanamivir (inhaled)
Antimicrobial agents General Approach to Infectious Diseases Penicillins
Antimicrobial chemotherapy
Antimicrobial resistance
Anti-MRSA cephalosporins agent ceftaroline adverse effects Anti-MRSA Cephalosporins spectrum
Antimycobacterial drugs
Antiparasitics
Antipseudomonal penicillins Penicillins Penicillin/Beta-lactamase Inhibitor Combinations
Antiretrovirals
Anti-SARS-COV-2 antibody therapies Anti-SARS-CoV-2 Antibody Therapies casirivimab/imdevimab sotrovimab adverse effects bamlanivimab/etesvimab mechanism of action tixagevimab/cilgavimab
Antistaphylococcal penicillins adverse effects of Antistaphylococcal Penicillins dicloxacillin methicillin nafcillin phlebitis and agents of described mechanism of action MSSA and oxacillin spectrum
Anaerobic intra-abdominal infections